| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |